Halozyme Acquires Drug Delivery Company Elektrofi
Halozyme has acquired Elektrofi to expand its drug delivery portfolio, with royalty revenues expected to start by 2030 as partnered products advance to clinical development.
Pharma
Thermo Fisher Opens Advanced Therapies Collaboration Center in Philadelphia
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness.
Johnson & Johnson Acquires Halda Therapeutics for $3.05 Billion
Johnson & Johnson is acquiring clinical-stage biotech Halda Therapeutics for $3.05 billion to enhance its oncology pipeline.
Novartis Launches $23 Billion North Carolina Manufacturing Hub
Novartis plans to establish a flagship manufacturing hub in North Carolina by 2027-2028 as part of a $23 billion investment in US infrastructure.
Navigating the Complexities of Early Drug Development
This infographic provides industry professionals and senior scientists with insights into detailed methodologies for addressing stability challenges in protein therapeutics.
50 Years of Expertise in Pharma & Healthcare
Europe-wide contract logistics for pharmaceuticals and healthcare - Loxxess and Michael Kuhn each bring 25 years of experience to the table - what does that mean?
Curia Invests $4 Million to Enhance Sterile API Manufacturing
Curia has completed a $4 million upgrade to its sterile API manufacturing suites in Valladolid, Spain, to enhance product quality, safety, and regulatory compliance.
Merck and Promega Collaborate on 3D Cell Technology for Drug Discovery
Merck and Promega intend to jointly develop innovative technologies to improve the screening and discovery of new active ingredients.
Hovione Completes $100 Million Investment to Expand Operations at US Manufacturing Site
Hovione has completed a $100 million investment to double spray-drying capacity and expand its East Windsor, New Jersey site, positioning the facility to meet growing US demand.
SK Pharmteco Invests $6.1 Million in Peptide Manufacturing at California Facility
SK Pharmteco has announced a $6.1 million investment to expand its Rancho Cordova, California, facility with new lab and kilo-scale capabilities for solid-phase peptide synthesis and purification.
Orion and Abzena Announce Exclusive Antibody Commercial License
Abzena, an end-to-end integrated CDMO for complex biologics and bioconjugates, announced that Orion has obtained an exclusive focused commercial license to one of Abzena’s mAbs..
Aenova Expands Fill & Finish Capacities at its Latina site
Aenova will install an additional filling and manufacturing line at the Latina, Italy, site. This expansion is an important step to meet the increasing global demand for the production of biologics.
BASF and IFF Launch Strategic Partnership for Next-Gen Enzyme and Polymer Innovations
The collaboration aims to accelerate the development of IFF's Designed Enzymatic Biomaterials technology platform and next-gen enzyme technologies for applications in cleaning and personal care products.
Sharp Services Invests $100 Million in US and European Facilities
Investments will bolster clinical and commercial capacity in US and Europe facilities for injectable and oral solid dose packaging, and sterile filling.
Cambrex Invests $120 Million to Expand US API Manufacturing
Cambrex announced a $120 million investment to expand its API manufacturing capacity at its Charles City, Iowa, facility by 40%.
ACG Invests $200 Million in US Hard-Shell Capsule Manufacturing
The investment will focus on developing gelatin and HPMC facilities, creating over 200 new jobs, and strengthening ACG’s 25-year presence in the US, with operations expected to begin in early 2027.
ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance
The ECA Foundation, one of the most important not-for-profit organizations for regulatory expertise in the pharmaceutical industry, aims to become the largest independent GMP/GDP organization in the world.
Pharma 4.0—the Key Enabler for Successful Digital Transformation in Pharma
Part 3: Seven Theses for successful Digitalization in Pharma
Transforming the Pharmaceutical Supply Chain
Effective and insightful solutions to the most pressing supply chain challenges facing pharmaceutical companies today.
Pharma 4.0 — the Key Enabler for Successful Digital Transformation in Pharma
Part 2: Digital transformation - 10 Years after the Start of Pharma 4.0
Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0
Pharma Strategies for Stability
Join us for a dynamic virtual event where science meets strategy.
Lilly to Build $6.5 Billion US Pharmaceutical Plant
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Houston, Texas.
Pfizer Agrees to Take Over Metsera for $4.9 Billion
Pfizer to acquire Metsera, a New York, NY-based clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.
Prange Pharma Acquires Site in Italy from MSD
Prange Pharma is taking over a production site from MSD Animal Health in Aprilia, Italy. A new center for contract manufacturing in the field of animal health products is to be established there.
Roche to Acquire 89Bio in $3.5 Billion Deal
Acquisition supports Roche’s strategy as it enhances the company’s portfolio in cardiovascular, renal, and metabolic diseases (CVRM) and offers optionality for future combination development.
GSK to Invest $30 Billion in US R&D and Manufacturing
Includes $1.2 billion in manufacturing facilities, AI, and advanced digital technologies, creating hundreds of highly skilled US jobs.
Performance Improvement in Pharmaceuticals Operations
The pharmaceutical industry has faced significant margin pressures due to rising energy costs, inflation, and geopolitical disruptions.
Stability in Motion
Amid global uncertainty, Bayer Pharma, led by Stefan Oelrich, pursues strategic transformation to boost resilience, drive innovation, and secure sustainable growth in a changing healthcare landscape.
LGC Opens $100 Million Pharma Synthesis Center in Canada
LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, Canada.
Smart Capacity Planning for Pharma & Biotech Company
How pharma & biotech company transformed warehouse capacity planning for strategic growth
Gilead Breaks Ground on New US Manufacturing Hub
New Bay Area building marks significant progress as part of Gilead's $32 billion US investment.
Genentech and Roche Break Ground on US Manufacturing Facility
The $700 million project is part of Genentech and Roche’s $50 billion investment in U.S. manufacturing, infrastructure and R&D
Cambrex Expands Peptide Manufacturing Capabilities in US
CDMO Cambrex announced that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts
Hongene to Supply exNA Oligonucleotide Technology Under New Licensing Deal
CDMO Hongene Biotech has entered a non-exclusive licensing agreement with the UMass Chan Medical School to produce and supply extended nucleic acid (exNA) monomers and exNA-modified oligonucleotides for research use.
